Collegium Pharmaceutical Inc
COLL
Get informed when a big investor buys or sells
+ FollowMarket Cap$879.28M
Close$
$17.40
36.7% downside
Current Fair Value
36.7% downsideOvervalued by 36.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $879.28 Million |
|---|---|
| Enterprise Value | $1.61 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.98 |
| Beta | 0.76 |
| Outstanding Shares | 32,460,783 |
Return
| Return on Equity | 15.36% |
|---|---|
| Return on Assets | 2.24% |
| Return on Invested Capital | 15.13% |
Valuation & Multiples
| P/E Ratio | 17.72 |
|---|---|
| PEG | -7.85 |
| Price to Sales | 1.15 |
| Price to Book Ratio | 3.06 |
| Enterprise Value to Revenue | 1.99 |
| Enterprise Value to EBIT | 6.88 |
| Enterprise Value to Net Income | 33 |
| Total Debt to Enterprise | 0.53 |
| Debt to Equity | 2.75 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$1.72
Average shareholder expectationRevenue Estimate
$199.63 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$1.86
Average shareholder expectationRevenue Estimate
$218.47 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.9076▲ 190.76% |
|---|---|
| Total Calls | 24,900▲ Infinity% |
| Total Puts | 47,500▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 128.19%▲ 8.40% |
|---|---|
| Total Invested | $1.48B▲ 17.46% |
| Investors Holding | 281▲ 14.00% |
ESG Score
No data
About Collegium Pharmaceutical Inc
CEO: Joseph Ciaffoni